Athersys, Inc. Prices Registered Direct Offering Of Common Stock And Warrants

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CLEVELAND, Jan. 10, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has entered into definitive agreements to sell 5,000,000 shares of common stock and warrants to purchase up to 1,500,000 shares of common stock, in an offering with gross proceeds of approximately $20.5 million. All of the participants in the offering are current shareholders of the company. The warrants are immediately exercisable. The warrants have an exercise price of $4.50 per share of common stock and expire on July 15, 2016. Each share of common stock, along with a warrant to purchase up to 0.30 shares of common stock, was offered for a purchase price of $4.10.

Help employers find you! Check out all the jobs and post your resume.

Back to news